Geraniin alleviates symptoms of acute migraine effectively in Sprague Dawley rats, offering new insights into migraine treatment.
The primary outcome measured was the reduction in migraine-like behaviors following geraniin administration, which was significant at multiple time points.
Analysis using a nitroglycerin-induced migraine model further supports the role of geraniin in migraine management for preclinical settings.
Findings highlight the promising therapeutic potential of geraniin as a natural intervention for migraine treatment in animal studies.